Target Price | $2,527.64 |
Price | $2,099.37 |
Potential | 20.40% |
Number of Estimates | 22 |
22 Analysts have issued a price target MercadoLibre 2026 . The average MercadoLibre target price is $2,527.64. This is 20.40% higher than the current stock price. The highest price target is $3,000.00 42.90% , the lowest is $2,250.00 7.18% . | |
A rating was issued by 26 analysts: 22 Analysts recommend MercadoLibre to buy, 3 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the MercadoLibre stock has an average upside potential 2026 of 20.40% . Most analysts recommend the MercadoLibre stock at Purchase. |
20 Analysts have issued a sales forecast MercadoLibre 2025 . The average MercadoLibre sales estimate is $25.8b . This is 24.36% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $27.2b 30.95% , the lowest is $24.9b 20.00% .
This results in the following potential growth metrics:
2024 | $20.8b | 37.53% |
---|---|---|
2025 | $25.8b | 24.36% |
2026 | $31.9b | 23.44% |
2027 | $38.3b | 20.03% |
2028 | $48.9b | 27.79% |
20 Analysts have issued an MercadoLibre EBITDA forecast 2025. The average MercadoLibre EBITDA estimate is $4.1b . This is 27.40% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $4.8b 46.67% , the lowest is $3.6b 10.47% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $3.1b | 18.53% |
---|---|---|
2025 | $4.1b | 33.40% |
2026 | $5.5b | 33.20% |
2027 | $7.0b | 27.31% |
2028 | $9.9b | 41.13% |
2024 | 14.93% | 13.81% |
---|---|---|
2025 | 16.02% | 7.30% |
2026 | 17.28% | 7.87% |
2027 | 18.33% | 6.08% |
2028 | 20.24% | 10.42% |
11 MercadoLibre Analysts have issued a net profit forecast 2025. The average MercadoLibre net profit estimate is $2.3b . This is 21.87% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.6b 37.65% , the lowest is $2.0b 3.61% .
This results in the following potential growth metrics and future Net Margins:
2024 | $1.9b | 94.78% |
---|---|---|
2025 | $2.3b | 21.87% |
2026 | $3.2b | 38.57% |
2027 | $4.0b | 23.88% |
2024 | 9.20% | 41.63% |
---|---|---|
2025 | 9.01% | 2.03% |
2026 | 10.12% | 12.32% |
2027 | 10.44% | 3.16% |
11 Analysts have issued a MercadoLibre forecast for earnings per share. The average MercadoLibre EPS is $45.93 . This is 21.86% higher than earnings per share in the financial year 2024. The highest EPS forecast is $51.88 37.65% , the lowest is $39.05 3.61% .
This results in the following potential growth metrics and future valuations:
2024 | $37.69 | 94.78% |
---|---|---|
2025 | $45.93 | 21.86% |
2026 | $63.65 | 38.58% |
2027 | $78.85 | 23.88% |
Current | 55.69 | 24.18% |
---|---|---|
2025 | 45.71 | 17.92% |
2026 | 32.98 | 27.85% |
2027 | 26.63 | 19.25% |
Based on analysts' sales estimates for 2025, the MercadoLibre stock is valued at an EV/Sales of 4.11 and an P/S ratio of 4.12 .
This results in the following potential growth metrics and future valuations:
Current | 5.10 | 2.00% |
---|---|---|
2025 | 4.11 | 19.51% |
2026 | 3.33 | 18.99% |
2027 | 2.77 | 16.69% |
2028 | 2.17 | 21.75% |
Current | 5.12 | 1.26% |
---|---|---|
2025 | 4.12 | 19.59% |
2026 | 3.34 | 18.99% |
2027 | 2.78 | 16.69% |
2028 | 2.18 | 21.75% |
Analyst | Rating | Action | Date |
---|---|---|---|
Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Apr 16 2025 |
Benchmark |
➜
Buy
|
Initiated | Apr 15 2025 |
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Apr 10 2025 |
Goldman Sachs |
Buy
➜
Buy
|
Unchanged | Mar 03 2025 |
JP Morgan |
Neutral
➜
Neutral
|
Unchanged | Feb 25 2025 |
Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Feb 21 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Feb 21 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Apr 16 2025 |
Initiated
Benchmark:
➜
Buy
|
Apr 15 2025 |
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Apr 10 2025 |
Unchanged
Goldman Sachs:
Buy
➜
Buy
|
Mar 03 2025 |
Unchanged
JP Morgan:
Neutral
➜
Neutral
|
Feb 25 2025 |
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Feb 21 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Feb 21 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.